Keppra

Keppra Chỉ định/Công dụng

levetiracetam

Nhà sản xuất:

UCB

Nhà tiếp thị:

GlaxoSmithKline
Thông tin kê toa chi tiết tiếng Anh
Indications/Uses
Levetiracetam is indicated as monotherapy in the treatment of: partial onset seizures with or without secondary generalisation in adults and adolescents from 16 years of age with newly diagnosed epilepsy.
Levetiracetam is indicated as adjunctive therapy in the treatment of: partial onset seizures with or without secondary generalisation in adults, adolescents, children from 4 years of age with epilepsy; myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy; primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with idiopathic generalised epilepsy.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập